The roles of tissue inhibitors of metalloproteinases in tissue remodelling and cell growth

International Journal of Obesity

Volumn 20, Issue SUPPL. 3, 1996, Pages

  Edwards, D R ^a   Beaudry, P P ^a   Laing, T D ^a   Kowal, V ^a   Leco, K J ^a   Leco, P A ^a   Lim, M S ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Cell growth; Gelatinases; Matrix metalloproteinases; Remodelling; Tissue inhibitors of metalloproteinases

Indexed keywords

GELATINASE; METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA;

CELL GROWTH; CONFERENCE PAPER; EXTRACELLULAR MATRIX; GENE CONTROL; OBESITY; PRIORITY JOURNAL; PROTEIN STRUCTURE; TISSUE;

ANIMALS; CELL DIVISION; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; GLYCOPROTEINS; HUMANS; METALLOENDOPEPTIDASES; SIGNAL TRANSDUCTION; TISSUE INHIBITOR OF METALLOPROTEINASES;

MAMMALIA;

EID: 0029969277     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (59)

1. Matrisian LM. The matrix-degrading metalloproteinases. BioEssays 1992; 14: 455-463.
2. Woessner JF, Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991; 5: 2145-2154.
3. Denhardt DT, Feng B, Edwards DR, Cocuzzi ET, Malyankar UM. Tissue inhibitor of metalloproteinases (TIMP, aka EPA): structure, control of expression and biological functions. Pharmac Ther 1993; 59: 329-341.
4. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991; 64: 327-336.
5. Brinckerhoff CE. Regulation of metalloproteinase gene expression: implications for osteoarthritis. Crit Rev Euk Gen Exp 1992; 2: 145-164.
6. Armstrong PW, Moe GW, Howard RJ, Grima EA, Cruz TF. Structural remodelling in heart failure: gelatinase induction. Can J Cardiol 1994; 10: 214-220.
7. Milani S, Herbst H, Schuppan D, Grappone C, Pellegrini G, Pinzani M, Casini A, Calabro A, Ciancio G, Stefanini F, Burroughs AK, Surrenti C. Differential expression of matrix metalloproteinase-1 and -2 genes in normal and fibrotic human liver. Am J Pathol 1994; 144: 528-537.
8. Khokha R, Zimmer MJ, Graham CH, Lala PK, Waterhouse P. Suppression of invasion by inducible expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in B16-F10 melanoma cells. J Natl Cancer Inst 1992; 84: 1017-1023.
9. DeClerck YA, Perez N, Shimada H, Boone TC, Langley KE, Taylor SM. Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res 1992; 52: 701-708.
10. Mohler KM, Sleath PR, Fitzner JN, Cerretti DP, Alderson M, Kerwar SS, Torrance DS, Otten-Evans C, Greenstreet T, Weerawarna K, Kronheim SR, Petersen M, Gerhart M, Kozlosky CJ, March CJ, Black RA. Protection against a lethal dose of endotoxin by an inhibitor of tumor necosis factor processing. Nature 1994; 370: 218-220.
11. Gearing AJH, Beckett P, Christodoulou M, Churchill M, Clements J, Davidson AH, Drummond AH, Galloway WA, Gilbert R, Gordon JL, Leber TM, Mangan M, Miller K, Nayee P, Owen K, Patel S, Thomas W, Wells G, Wood LM, Woolley K. Processing of tumour necrosis factor-α precursor by metalloproteinases. Nature 1994; 370: 555-557.
12. McGeehan GM, Becherer JD, Bast RC, Jr, Boyer CM, Champion B, Connolly KM, Conway JG, Furdon P, Karp S, Kidao S, McElroy AB, Nichols J, Pryzwansky KM, Schoenen F, Sekut L, Truesdale A, Verghese M, Warner J, Ways JP. Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor. Nature 1994; 370: 558-561.
13. Williamson RA, Marsto FAO, Angal S, Koklitis P, Panico M, Morris HR, Carne AF, Smith BJ, Harris TJR, Freedman RB. Disulphide bond assignments in human tissue inhibitor of metalloproteinases (TIMP). Biochem J 1990; 268: 267-274.
14. Murphy G, Houbrechts A, Cockett MI, Williamson RA, O'Shea M, Docherty AJP. The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity. Biochemistry 1991; 30: 8097-8102.
15. DeClerck YA, Yean T-D, Lee Y, Tomich JM, Langley KE. Characterization of the functional domain of tissue inhibitor of metalloproteinases-2 (TIMP-2). Biochem J 1993; 289: 65-69.
16. O'Shea M, Willenbrock F, Williamson RA, Cockett MI, Freedman RB, Reynolds JJ, Docherty AJP, Murphy G. Site-directed mutations that alter the inhibitory activity of the tissue inhibitor of metalloproteinases-1: importance of the N-terminal region between cysteine 3 and cysteine 13. Biochemistry 1992; 31: 10146-10152.
17. Boden MK, Harber GJ, Birkedal-Hansen B, Windsor LJ, Caterina NCM, Engler JA, Birkedal-Hansen H. Functional domains of human TIMP-1 (tissue inhibitor of metalloproteinases). J Biol Chem 1994; 269: 18943-18952.
18. Kleiner DE, Stetler-Stevenson WG. Structural biochemistry and activation of the matrix metalloproteinases. Curr Op Cell Biol 1993; 5: 891-897.
19. Leco KJ, Khokha R, Pavloff N, Hawkes SP, Edwards DR. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J Biol Chem 1994; 269: 9352-9360.
20. Pavloff N, Staskus PW, Kishnani NS, Hawkes SP. A new inhibitor of metalloproteinases from chicken: ChIMP-3. J Biol Chem 1992; 267: 7321-17326.
21. Yang B, Yang BL, Savani RC, Turley EA. Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein. EMBO J 1994; 13: 286-296.
22. Weber BHF, Vogt G, Pruett RC, Stohr H, Felbor U. Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP-3) in patients with Sorsby's fundus dystrophy. Nature Genetics 1994; 8: 352-355.
23. Howard EW, Bullen EC, Banda MJ. Preferential inhibition of 72- and 92-kDa gelatinases by tissue inhibitor of metalloproteinases-2. J Biol Chem 1991; 266: 13070-13075.
24. Willenbrock F, Crabbe T, Slocombe PM, Sutton CW, Docherty AJP, Cockett MI, O'Shea M, Brocklehurst K, Phillips IR, Murphy G. The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions: a kinetic analysis of the inhibition of gelatinase-A. Biochemistry 1993; 32: 4330-4337.
25. Staskus PW, Masiarz FR, Pallanck LJ, Hawkes SP. The 21-kDa protein is a transformation-sensitive metalloproteinase inhibitor of chicken fibroblasts. J Biol Chem 1991; 266: 449-454.
26. Behrendtsen O, Alexander CM, Werb Z. Metalloproteinases mediate extracellular matrix degradation by cells from mouse blastocyst outgrowths. Development 1992; 114: 447-456.
27. Librach CL, Werb Z, Fitzgerald ML, Chiu K, Corwin NM, Esteves RA, Grobelny D, Galardy R, Damsky CH, Fisher SJ. 92-kDa type IV collagenase mediates invasion of human cytotrophoblasts. J Cell Biol 1991; 113: 437-449.
28. Harvey MB, Leco KJ, Arcellana-Panlillio MY, Zhang X, Edwards DR, Schultz GA. Proteinase expression in early mouse embroyos is regulated by leukemia inhibitory factor and epidermal growth factor. Development 1995; 121: 1183-1198.
29. Adams JC, Watt FM. Regulation of development and differentiation by the extracellular matrix. Development 1993; 117: 1183-1198.
30. Lloyd Jones P, Schmidhausen C, Bissell MJ. Regulation of gene expression and cell function by the extracellular matrix. Crit Rev Euk Gene Exp 1993; 3: 37-154.
31. Talhouk RS, Bissell MJ, Werb Z. Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution. J Cell Biol 1992; 118: 1271-1282.
32. Yayon A, Klagsbrun M, Esko Leder P, Ornitz DM. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 1991; 64: 841-848.
33. Lopez-Casillas F, Wrana JL, Massague J. Betaglycan presents ligand to the TGF-β signalling receptor. Cell 1993; 73: 1435-1444.
34. Yamaguchi Y, Mann DM, Ruoslahti E. Negative regulation of transforming growth factor-β by the proteoglycan decorin. Nature 1990; 346: 281-284.
35. Avalos BR, Kaufman SE, Tomonaga M, Williams RE, Golde DW, Gasson JC. K562 cells produce and respond to human erythroid potentiating activity. Blood 1988; 71: 1720-1725.
36. Bertaux B, Hornebeck W, Eisen AZ, Dubertret L. Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases. J Invest Dermatol 1991; 97: 670-685.
37. Hayakawa T, Yamashita K, Uchijima E, Iwata K. Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. FEBS Letts 1992; 298: 29-32.
38. Nemeth JA, Goolsby CL. TIMP-2, a growth-stimulatory protein from SV40-transformed human fibroblasts. Exp Cell Res 1993; 207: 376-382.
39. Hayakawa T, Yamashita K, Ohuchi E, Shinagawa A. Cell growth promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2). J Cell Sci 1994; 107: 2373-2379.
40. Murphy AN, Unsworth EJ, Stetler-Stevenson WG. Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. J Cell Physiol 1993; 157: 351-358.
41. Khokha R, Waterhouse P, Yagel S, Lala PK, Overall CM, Norton G, Denhardt DT. Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. Science 1989; 243: 947-950.
42. Khokha R. Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by overexpression of the tissue inhibitor of metalloproteinases-1. J Natl Canc Inst 1994; 86: 299-304.
43. Koop S, Khokha R, Schmidt EE, MacDonald IC, Morris VL, Chambers AF, Groom AC. Overexpression of metalloproteinase inhibitor in B16F10 cells does not affect extravasation but reduces tumor growth. Cancer Res 1994; 54: 4791-4797.
44. Yang T-T, Hawkes SP. Role of the 21-kDa protein TIMP-3 in oncogenic transformation of cultured chicken embryo fibroblasts. Proc Natl Acad Sci USA 1992; 89: 10676-10680.
45. 1 progression, mitogenic stimulation, differentiation and senescence. J Biol Chem 1994; 269: 18953-18960.
46. Corcoran ML, Stetler-Stevenson WG. Tissue inhibitor of metalloproteinases-2 (TIMP-2) stimulates fibroblast profileration via a cycli adenosine 3′,5′-monophosphate (cAMP)-dependent mechanism. J Biol Chem 1995; 270: 13453-13459.
47. Campbell CE, Flenniken AM, Skup D, Williams BRG. Identification of a serum- and phorbol ester-responsive element in the murine tissue inhibitor of metalloproteinase gene. J Biol Chem 1991; 266: 7199-7206.
48. Edwards DR, Rocheleau H, Sharma RR, Wills AJ, Cowie A, Hassell JA, Heath JK. Involvement of API and PEA3 binding sites in the regulation of murine tissue inhibitor of metalloproteinases-1 (TIMP-1) transcription. Biochim Biophys Acta 1992; 1171: 41-55.
49. Leco KJ, Hayden LJ, Sharma RR, Rocheleau H, Greenberg AH, Edwards DR. Differential regulation of TIMP-1 and TIMP-1 mRNA expression in normal and Ha-ras-transformed murine fibroblasts. Gene 1992; 117: 209-217.
50. DeClerck YA, Darvill MI, Eeckhout Y, Rousseau GG. Characterization of the promoter of the gene encoding human tissue inhibitor of metalloproteinases-2 (TIMP-2). Gene 1994; 139: 185-191.
51. Uchijima M, Sato H, Fujii M, Seiki M. Tax proteins of human T-cell leukemia virus type 1 and 2 induce expression of the gene encoding eryhtroid potentiating activity (tissue inhibitor of metalloproteinases-1, TIMP-1). J Biol Chem 1994; 269: 14946-14950.
52. Ponton A, Coulombe B, Steyaert A, Williams BRG, Skup D. Basal expression of the gene (TIMP) encoding the murine tissue inhibitor of metalloproteinases is medicated through API- and CCAAT-binding factors. Gene 1992; 116: 187-194.
53. Gaire M, Magbanua Z, McDonnell S, McNeil L, Lovett DH, Matrisian LM. Structure and expression of the human gene for the matrix metalloproteinase matrilysin. J Biol Chem 1994; 269: 2032-2040.
54. Nomura S, Hogan BLM, Wills AJ, Heath JK, Edwards DR. Developmental expression of tissue inhibitor of metalloproteinase (TIMP) RNA. Development 1989; 105: 575-583.
55. Waterhouse P, Denhardt DT, Khokha R. Temporal expression of tissue inhibitors of metalloproteinases in mouse reproductive tissues during gestation. Mol Reprod Dev 1993; 35: 219-226.
56. Apte SS, Hayashi K, Seldi MF, Mattei M-G, Hayashi M, Olsen B. Gene encoding a novel murine tissue inhibitor of metalloproteinases (TIMP), TIMP-3, is expressed in developing mouse epithelia, cartilage and muscle and is located on mouse chromosome 10. Develop Dynam 1994; 200: 177-197.
57. Flier JS. The adipocyte: storage depot or node on the energy information superhighway. Cell 1995; 80: 5-18.
58. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 1993; 259: 87-91.
59. Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM. Tumor necrosis factor-a inhibits signaling from the insulin receptor. Proc Natl Acad Sci USA 1994; 91: 4854-4858.